Netherlands· NL-6a5e9a8fb06d

Zaditen 1 mg, tabletten

A ketotifen product containing ketotifenwaterstoffumaraat, registered in Netherlands by Alfasigma S.p.A.. The same ATC class is registered in 11 of our 19 countries.

ATC R06AX17

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ketotifenwaterstoffumaraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ketotifen is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX17 (ketotifen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search ketotifen products by name

Ketotifen · ATC R06AX17

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ketotifen costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ketotifen · price per daily dose (2 mg)

USD · FX 28 Sept 2026

IT Italy$0.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: KETOTIFENWATERSTOFFUMARAAT
Manufacturer: Alfasigma S.p.A.
Country: Netherlands (NL)
ATC code: R06AX17
ATC class: Ketotifen
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
08319

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for ketotifen.

Graded by severity as the source publishes them — 108 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ketotifen against other medicines How interaction checks work

Ketotifen · interactions on record

108 records

108 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Ketotifen in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ketotifen products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Ketotifen Stulln, Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln
Belgium · Altriabak, Ketazed
Bulgaria · Ketotifen Sopharma, Забак
Cyprus · Meni-Drops, Tenerel
Czechia · Ketof, Ketotifen Al
Germany · Allergo-Vision Sine, Ketazed
Denmark · Ketazed, Zaditen
Spain · Bentifen, Ketisal
Finland · Ketazed, Ketotifen Stulln 0,25 Mg/Ml Silmätipat, Liuos
France · Ketazed, Monoketo
United Kingdom (Northern Ireland) · Ketazed, Ketofall
Greece · Cleroptic, K-Drops
Ireland · Ketofall, Zaditen
Iceland · Zaditen
Italy · Brunistill, Chetotifene Mylan Generics
Luxembourg · Altriabak, Ketazed
Latvia · Ketotifen
Norway · Ketazed, Zaditen
Poland · Ketotifen Hasco, Ketotifen Stulln
Portugal · Lidina, Lidinafree
Romania · Ketazed, Ketof
Sweden · Bentifen, Ketazed
Slovenia · Zaditen, Zaditen Sdu
Slovakia · Denerel, Zaditen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9736c17d-c364-46fb-af33-d65df30ffae2
GET /v1/drugs/9736c17d-c364-46fb-af33-d65df30ffae2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08319_smpc.pdf",
  "strength": null,
  "atc_label": "Ketotifen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg08319",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MAÏSZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "KETOTIFENWATERSTOFFUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h08319.pdf",
  "authorised_at": "1979/07/27",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "08319",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ketotifen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console